Exhibit 23.1
| Proof KPMG Audit 51 rue de Saint-Cyr CS 60409 69338 Lyon Cedex 9 Lyon | Téléphone : +33 (0)4 37 64 76 00 Télécopie : +33 (0)4 37 64 76 09 Site internet : www.kpmg.fr |
Erytech Pharma S.A.
Head office: 60 avenue Rockefeller - 69008 - Lyon
Consent of independent Registered Public Accounting Firm
The Board of Directors,
We consent to the incorporation by reference in this registration statement on Form S-8 of ERYTECH Pharma S.A. of our report dated March 8, 2021, with respect to the consolidated statements of financial position of ERYTECH Pharma S.A. and its subsidiary as of December 31, 2020, 2019 and 2018, and the related consolidated statements of income (loss), comprehensive income (loss), changes in shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2020, and the related notes, which report appears in the Annual Report on Form 20-F of ERYTECH Pharma S.A for the year ended December 31, 2020 filed with the US. Securities and Exchange Commission on March 8, 2021.
Our report dated March 8, 2021 refers to the change in ERYTECH Pharma S.A.’s method of accounting for leases on January 1, 2019, due to the adoption of IFRS 16 “Leases”.
Lyon, May 7, 2021
KPMG Audit
A division of KPMG S.A.
/s/ Stéphane Devin
Stéphane Devin
Partner
KPMG S.A., société française membre du réseau KPMG constitué de cabinets indépendants adhérents de KPMG Internatinal Cooperative, une entité de droit suisse. Error! Unknown document property name. | Société anonyme d’expertise comptable et de commissariat aux comptes à directoire et conseil de surveillance. Inscrite au Tableau de l’Ordre à Paris sous le n° 14-30080101 et à la Compagnie Régionale des Commissaires aux Comptes de Versailles. | Siège social : KPMG S.A. Tour Eqho 2 avenue Gambetta 92066 Paris la Défense Cedex Capital : 5 497 100 €. Code APE 6920Z 775 726 417 R.C.S. Nanterre TVA Union Européenne FR 77 775 726 417 |
